Five hundred people in the Canadian province of New Brunswick were diagnosed with a "mystery brain disorder" that resembled ...

An international clinical trial is testing whether a simple finger-prick blood test could help identify Alzheimer's disease ...

A blood test, combined with an ultrathin material derived from graphite, could significantly advance efforts to detect ...

Researchers at Rutgers Robert Wood Johnson Medical School in New Brunswick are enrolling participants in the National ...

What if screening for the diseases that cause dementia could start with something as quick as a finger-prick blood test?

A large McGill University study has found that two classes of medications commonly prescribed for type 2 diabetes, both ...

Updated guidance on vascular cognitive impairment emphasizes executive function and processing speed, endorses brief, ...

Neumora Therapeutics’ oral Alzheimer’s disease agitation drug has shown benefit, reducing agitation, in a Phase Ib trial.

The study also leveraged advanced diagnostic tools to identify early biomarkers of cognitive decline in individuals with a ...

Funds to support ongoing Phase 1 trial of MNA-001 and validation of translational biomarkers for TREM2 function in Alzheimer's Work will inform Phase 2 trials assessing the potential of MNA-001 to ...

Despite longstanding guidelines, many dementia patients are still prescribed brain-altering medications that can raise the ...

A new drug candidate shows promise by reversing cognitive decline in advanced Alzheimer's disease by restoring brain balance ...